Skip to main content
. Author manuscript; available in PMC: 2010 Aug 31.
Published in final edited form as: Ann Thorac Surg. 2009 Jun;87(6):1973–1980. doi: 10.1016/j.athoracsur.2008.12.095

Table 1.

Thymoma Classification Systems

Classification System
Lattes/Bernatz Traditional description of the dominant cell type
Muller-Hermelink Presumed origin of the malignant cell (corticomedullary classification)
WHO Based on the traditional descriptive classification and the corticomedullary classification
WHO type Histologic criteria
A Bland spindle/oval epithelial tumor cells with few or no lymphocytes. (Synonyms: spindle cell thymoma; medullary thymoma)
AB Mixture of a lymphocyte-poor type A thymoma component and a more lymphocyte-rich type B-like component. (Synonyms: mixed thymoma)
B1 Histological appearance of normal thymus, composed predominantly of areas resembling cortex with epithelial cells scattered in a predominant population of immature lymphocytes, and areas of medullary differentiation. (Synonyms: lymphocyte-rich thymoma; predominantly cortical thymoma)
B2 Large, polygonal tumor cells that are arranged in a loose network and exhibit large vesicular nuclei with prominent large nucleoli – background population of immature T-cells always present. (Synonyms: cortical thymoma)
B3 Predominantly medium-sized round or polygonal cells with slight atypia. Epithelial cells are mixed with minor component of intraepithelial lymphocytes. (Synonyms: well-differentiated thymic carcinoma; epithelial thymoma; squamoid thymoma)
C Heterogeneous group of thymic carcinomas
Masaoka Presence of invasion and anatomic extent of involvement (clinically and histopathologically)
I Macroscopically completely encapsulated and microscopically no capsular invasion
II Microscopic invasion into capsule (IIa) or macroscopic invasion into surrounding fatty tissue or mediastinal pleura (IIb)
III Macroscopic invasion into neighboring organs (ie, pericardium, great vessels, or lung)
IVa Pleural or pericardial dissemination
IVb Lymphogenous or hematogenous metastasis

WHO = World Health Organization.